RAGE-mediated inflammation, type 2 diabetes, and diabetic vascular complication

Frontiers in Endocrinology

Volumn 4, Issue AUG, 2013, Pages

  Yamamoto, Yasuhiko ^a   Yamamoto, Hiroshi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Inflammation; Obesity; Pattern recognition receptors; Rage; Toll like receptors

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HIGH MOBILITY GROUP B1 PROTEIN; LYSOPHOSPHATIDIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PROTEIN CDC42; PROTEIN KINASE C; S100 CALCIUM BINDING PROTEIN G; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR;

ALLELE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BINDING AFFINITY; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGEN CLEARANCE; PROTEIN EXPRESSION; RECEPTOR POTENTIAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84884200239     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00105     Document Type: Review

References (25)

1. Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation - mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol (2012) 32:1771-6. doi:10.1161/ATVBAHA.111.241869
2. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 11:98-107. doi:10.1038/nri2925
3. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest (2006) 116:1793-801. doi:10.1172/JCI29069
4. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, et al. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 267:14998-5004.
5. Yamamoto Y, Yamamoto H. RAGE-mediated inflammation and diabetic vascular complications. J Diabetes Invest (2011) 2:155-7. doi:10.1111/j.2040-1124.2011.00125.x
6. Yan SF, Yan SD, Ramasamy R, Schmidt AM. Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation. Ann Med (2009) 25:1-15. doi:10.1080/07853890902806576
7. Christaki E, Opal SM, Keith JC Jr, Kessimian N, Palardy JE, Parejo NA, et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock (2011) 35:492-8. doi:10.1097/SHK.0b013e31820b2e1c
8. Mizumoto S, Takahashi J, Sugahara K. Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells. J Biol Chem (2012) 287:18985-94. doi:10.1074/jbc.M111.313437
9. Yamamoto Y, Yamamoto H. Controlling RAGE to conquer diabetic vascular complications. J Diabetes Invest (2012) 3:107-14. doi:10.1111/j.2040-1124.2011.00191.x
10. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A, et al. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS ONE (2011) 6:e23132. doi:10.1371/journal.pone.0023132
11. Tsan MF. Heat shock proteins and high mobility group box 1 protein lack cytokine function. J Leukoc Biol (2011) 89:847-53. doi:10.1189/jlb.0810471
12. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8:487-96. doi:10.1038/ni1457
13. Qin YH, Dai SM, Tang GS, Zhang J, Ren D, Wang ZW, et al. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products. J Immunol (2009) 183:6244-50. doi:10.4049/jimmunol.0900390
14. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem (2004) 279:7370-7. doi:10.1074/jbc.M306793200
15. Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta (2009) 1793:993-1007. doi:10.1016/j.bbamcr.2008.11.016
16. Turovskaya O, Foell D, Sinha P, Vogl T, Newlin R, Nayak J, et al. RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis (2008) 29:2035-43. doi:10.1093/carcin/bgn188
17. Vogl T, Tenbrock K, Ludwig S, Leukert N, Ehrhardt C, van Zoelen MA, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med (2007) 13:1042-9. doi:10.1038/nm1638
18. He M, Kubo H, Morimoto K, Fujino N, Suzuki T, Takahasi T, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep (2011) 12:358-64. doi:10.1038/embor.2011.28
19. Yamamoto Y, Harashima A, Saito H, Tsuneyama K, Munesue S, Motoyoshi S, et al. Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol (2011) 186:3248-57. doi:10.4049/jimmunol.1002253
20. Ueno H, Koyama H, Shoji T, Monden M, Fukumoto S, Tanaka S, et al. Receptor for advanced glycation end-products (RAGE) regulation of adiposity and adiponectin is associated with atherogenesis in apoE-deficient mouse. Atherosclerosis (2000) 211:431-6. doi:10.1016/j.atherosclerosis.2010.04.006
21. Monden M, Koyama H, Otsuka Y, Morioka T, Mori K, Shoji T, et al. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: involvement of Toll-like receptor 2. Diabetes (2013) 62:478-89. doi:10.2337/db11-1116
22. Osawa M, Yamamoto Y, Munesue S, Murakami N, Sakurai S, Watanabe T, et al. De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts. Biochim Biophys Acta (2007) 1770:1468-74. doi:10.1016/j.bbagen.2007.07.003
23. Han Z, Liu Q, Sun C, Li Y. The interaction between obesity and RAGE polymorphisms on the risk of knee osteoarthritis in Chinese population. Cell Physiol Biochem (2012) 30:898-904. doi:10.1159/000341467
24. Kim OY, Jo SH, Jang Y, Chae JS, Kim JY, Hyun YJ, et al. G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects. Nutr Res (2009) 29:106-13. doi:10.1016/j.nutres.2009.01.006
25. Han D, Yamamoto Y, Munesue S, Motoyoshi S, Saito H, Win MT, et al. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes. Genes Cells (2013) 18:302-14. doi:10.1111/gtc.12036